autologous dendritic cell-adenovirus p53 vaccine

BIOLOGICAL3 trials

Sponsors

H. Lee Moffitt Cancer Center and Research Institute, University of Nebraska, National Institutes of Health Clinical Center (CC)

Conditions

Breast CancerKidney CancerLung CancerMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific

Phase 1

Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

CompletedNCT00049218

H. Lee Moffitt Cancer Center and Research InstituteLung Cancer

Start: 2003-04-30End: 2014-05-31Updated: 2014-05-09

Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer

CompletedNCT00082641

University of NebraskaBreast Cancer

Start: 2004-01-01End: 2018-01-01Updated: 2023-09-22

Phase 2

Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer

TerminatedNCT00704938

National Institutes of Health Clinical Center (CC)Kidney Cancer, Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific

Start: 2008-06-30End: 2009-08-31Updated: 2015-10-28